Analysts Conflicted on These Healthcare Names: Guardant Health (GH), AMN Healthcare Services (AMN) and Community Health (CYH)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Guardant Health (GH – Research Report), AMN Healthcare Services (AMN – Research Report) and Community Health (CYH – Research Report).
President's Day Sale - 70% Off
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Guardant Health (GH)
In a report released today, Dan Leonard from UBS reiterated a Buy rating on Guardant Health, with a price target of $175.00. The company’s shares closed last Thursday at $106.38.
According to TipRanks.com, Leonard is a 5-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Guardant Health with a $132.65 average price target, a 24.4% upside from current levels. In a report issued on February 17, Robert W. Baird also initiated coverage with a Buy rating on the stock with a $120.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
AMN Healthcare Services (AMN)
Truist Financial analyst Tobey Sommer maintained a Buy rating on AMN Healthcare Services today. The company’s shares closed last Thursday at $17.28.
According to TipRanks.com, Sommer is a 5-star analyst with an average return of
AMN Healthcare Services has an analyst consensus of Moderate Buy, with a price target consensus of $23.33.
Community Health (CYH)
UBS analyst A.J. Rice maintained a Hold rating on Community Health today and set a price target of $3.70. The company’s shares closed last Thursday at $3.52.
According to TipRanks.com, Rice is a 5-star analyst with an average return of
Community Health has an analyst consensus of Hold, with a price target consensus of $3.70, implying a 19.0% upside from current levels. In a report released yesterday, Barclays also maintained a Hold rating on the stock with a $3.50 price target.
